Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
business update
Evaxion to announce business update and full year 2024 financial results on April 1, 2025
27 mars 2025 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a...
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
21 mars 2025 08h00 HE
|
Biofrontera Inc.
Conference scheduled for Friday, March 21, 2025 at 10:00 a.m. Eastern time Woburn, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical...
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
27 févr. 2025 08h05 HE
|
Imunon, Inc.
IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in Q1...
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
26 févr. 2025 07h00 HE
|
MoonLake Immunotherapeutics AG
Initiated the Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 IZAR program in patients with active psoriatic...
IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025
20 févr. 2025 08h30 HE
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company...
Travere Therapeutics Provides Corporate Update and 2025 Outlook
13 janv. 2025 07h00 HE
|
Travere Therapeutics, Inc.
Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net product sales of FILSPARI for the fourth quarter sNDA...
Hyperscale Data Issues Business Update to Stockholders
09 déc. 2024 06h30 HE
|
Hyperscale Data, Inc.
Hyperscale Data Issues Business Update to Stockholders
Company in Negotiations to Develop and Lease its Michigan Data Center in a Significant Transaction
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
12 nov. 2024 16h05 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Evaxion announces business update and third quarter 2024 financial results
31 oct. 2024 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business...
DHT Holdings, Inc.: Business Update
09 oct. 2024 16h15 HE
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, October 9, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the third quarter of 2024, the Company estimates time...